Skip to main content

Table 1 Study and patient characteristics of the included studies

From: Comparative diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and Bayesian network meta-analysis

Author, year

Type of imaging test

Study characteristics

Patient characteristics

Country

Study design

Reference standard

No. of patients

Mean/Median age

Male/Female

Adamek et al. 2000

MRCP vs. ERCP

Germany

Pro

Pathology and/or follow-up imaging

124

Mean(range):55.1(19–80)

76/48

Buscail et al. 1995

US vs. ERCP vs. CT vs. EUS

France

Pro

Pathology and/or follow-up imaging

81

Mean ± SD: (51 ± 12)

60/21

Dramaix et al. 1980

US vs. CT

France

Pro

Pathology and/or follow-up imaging

50

NA

33/17

Engjom et al. 2018

US vs. EUS

Norway

Pro

Follow-up imaging

92

Mean ± SD: (54 ± 15.3)

36/56

Fusari et al. 2010

MRI vs. CT

Italy

Pro

Pathology

40

Mean ± SD: (62 ± 13)

22/18

Gebel et al. 1985

US vs. ERCP

France

Retro

NA

56

NA

NA

Glasbrenner et al. 2000

EUS vs. ERCP

Germany

Pro

Pathology

95

Median(range):54(20–75)

67/28

Gmelin et al. 1981

US vs. ERCP vs. CT

Germany

Pro

Pathology and/or follow-up imaging

41

Mean:54

28/13

Lammer et al. 1980

CT vs. ERCP

Germany

NA

NA

107

NA

NA

Lawson et al. 1978

US vs. ERCP

USA

Retro

Pathology and/or follow-up imaging

75

NA

NA

Lin et al. 1989

US vs. EUS

China

NA

NA

33

NA

NA

Nordaas et al. 2021

US vs. CT

Norway

Cross-sectional

Follow-up imaging

73

Mean ± SD: (54 ± 13)

30/43

Pungpapong et al. 2007

MRCP vs. EUS

USA

Pro

Pathology and/or follow-up imaging

99

Mean ± SD: (55 ± 14)

47/52

Scarabino et al. 1989

US vs. ERCP vs. CT

Italy

NA

NA

63

NA

NA

Schlaudraff et al. 2008

MRCP vs. sMRCP

Germany

Pro

Pathology and/or follow-up imaging

67

Mean ± SD: (56 ± 15)

36/31

Swobodnik et al. 1983

US vs. ERCP vs. CT

Germany

Pro

Pathology and/or follow-up imaging

75

Mean(range):49.3(27–82)

42/33

Zuccaro et al. 2009

MRCP vs. sMRCP

USA

Retro

Follow-up imaging

69

Mean ± SD: (43.5 ± 12)

24/45

  1. EUS ultrasonography; ERCP endoscopic retrograde cholangiopancreatography; MRI magnetic resonance imaging; CT computed tomography; US ultrasonography; MRCP magnetic resonance cholangiopancreatography; sMRCP secretin-enhanced magnetic resonance cholangiopancreatography; TP true positive; PB patient-based; LB lesion-based; Pro prospective; Retro retrospective; TP true positive; TN true negative; FP false positive; FN false positive; NA not available